CareDx, Inc (CDNA)
Largest Insider Buys in Sector
CDNA Stock Price History Chart
CDNA Stock Performance
About CareDx, Inc
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company also offers TruSight HLA, a next generation sequencing (NGS) based high resolution typing solution; Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; and XynQAPI transplant quality tracking and waitlist management solutions, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.
Insider Activity of CareDx, Inc
Over the last 12 months, insiders at CareDx, Inc have bought $0 and sold $4.66M worth of CareDx, Inc stock.
On average, over the past 5 years, insiders at CareDx, Inc have bought $240,266 and sold $21.22M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 5,000 shares for transaction amount of $211,694 was made by Dhingra Ankur (Chief Financial Officer) on 2021‑11‑24.
List of Insider Buy and Sell Transactions, CareDx, Inc
| 2024-12-04 | Sale | Secretary and General Counsel | 1,917 0.0036% | $26.00 | $49,842 | -4.05% | ||
| 2024-11-26 | Sale | director | 5,000 0.0093% | $25.00 | $125,000 | -0.64% | ||
| 2024-11-25 | Sale | Secretary and General Counsel | 1,223 0.0023% | $24.00 | $29,352 | +3.69% | ||
| 2024-11-18 | Sale | Secretary and General Counsel | 5,534 0.0104% | $21.77 | $120,477 | +9.70% | ||
| 2024-08-21 | Sale | See Remarks | 21,557 0.0399% | $32.58 | $702,327 | -18.23% | ||
| 2024-08-20 | Sale | director | 35,552 0.0686% | $33.04 | $1.17M | -15.47% | ||
| 2024-08-20 | Sale | See Remarks | 39,466 0.0765% | $33.17 | $1.31M | -15.47% | ||
| 2024-08-19 | Sale | See Remarks | 34,231 0.0641% | $33.55 | $1.15M | -18.93% | ||
| 2023-10-02 | Sale | See Remarks | 2,818 0.0052% | $6.91 | $19,483 | +48.03% | ||
| 2023-09-05 | Sale | See Remarks | 2,819 0.0054% | $9.49 | $26,762 | +7.49% | ||
| 2023-08-14 | Sale | See Remarks | 576 0.001% | $8.89 | $5,123 | +3.96% | ||
| 2023-08-02 | Sale | See Remarks | 2,819 0.0053% | $11.35 | $31,988 | -13.85% | ||
| 2023-07-13 | Sale | See Remarks | 5,260 0.01% | $10.33 | $54,357 | -3.86% | ||
| 2023-07-13 | Sale | director | 5,000 0.0095% | $10.34 | $51,681 | -3.86% | ||
| 2023-07-03 | Sale | See Remarks | 2,818 0.0052% | $8.48 | $23,901 | +14.49% | ||
| 2023-06-28 | Sale | See Remarks | 14,268 0.0266% | $8.76 | $125,016 | +10.72% | ||
| 2023-06-28 | Sale | director | 2,432 0.0045% | $8.72 | $21,216 | +10.72% | ||
| 2023-06-02 | Sale | See Remarks | 2,819 0.0053% | $8.13 | $22,911 | +14.51% | ||
| 2023-05-02 | Sale | See Remarks | 2,819 0.0054% | $8.12 | $22,898 | +11.00% | ||
| 2023-04-03 | Sale | See Remarks | 2,818 0.0054% | $8.95 | $25,225 | +0.34% |
Insider Historical Profitability
| Maag Peter | director | 330024 0.6153% | $24.96 | 4 | 55 | +57.09% |
| Johnson Alexander L | See Remarks | 284983 0.5313% | $24.96 | 0 | 3 | |
| Novack Jeffrey Adam | Secretary and General Counsel | 110237 0.2055% | $24.96 | 0 | 3 | |
| TPG Group Holdings (SBS) Advisors, Inc. | 10 percent owner | 1075090 2.0045% | $24.96 | 1 | 0 | <0.0001% |
| BYERS BROOK H | 751174 1.4006% | $24.96 | 1 | 0 | <0.0001% | |
| KLEINER PERKINS CAUFIELD & BYERS X A LP | 10 percent owner | 751174 1.4006% | $24.96 | 1 | 0 | <0.0001% |
| Seeto Reginald | See Remarks | 479164 0.8934% | $24.96 | 0 | 34 | |
| Gagnon Neil | 10 percent owner | 107940 0.2013% | $24.96 | 48 | 1 | +71.45% |
| Bell Michael Brian | Chief Financial Officer | 103343 0.1927% | $24.96 | 1 | 10 | +288.89% |
| Nelles Mitchell J | Chief Operating Officer | 85160 0.1588% | $24.96 | 1 | 2 | <0.0001% |
| Goldberg Michael | 62267 0.1161% | $24.96 | 1 | 12 | <0.0001% | |
| SNYDERMAN RALPH | director | 51015 0.0951% | $24.96 | 0 | 5 | |
| Yee James P | Chief Medical Officer | 42045 0.0784% | $24.96 | 0 | 5 | |
| King Sasha | Chief Marketing Officer | 40139 0.0748% | $24.96 | 0 | 16 | |
| Bickerstaff George | director | 37736 0.0704% | $24.96 | 0 | 5 | |
| HAGSTROM WILLIAM A | director | 18575 0.0346% | $24.96 | 0 | 6 | |
| Whitson Todd | Chief Commercial Officer | 10000 0.0186% | $24.96 | 1 | 0 | <0.0001% |
| LUDLUM KEN | Chief Financial officer | 5000 0.0093% | $24.96 | 1 | 0 | <0.0001% |
| Dhingra Ankur | Chief Financial Officer | 5000 0.0093% | $24.96 | 1 | 0 | <0.0001% |
| Colon Grace | 4864 0.0091% | $24.96 | 0 | 3 | ||
| TORRES ARTHUR A | director | 2855 0.0053% | $24.96 | 1 | 0 | <0.0001% |
Institutional Investor Ownership
| ARK Investment Management LLC | $62.1M | 11.26 | 5.86M | -18.5% | -$14.09M | 0.22 | |
| BlackRock | $57.45M | 10.42 | 5.43M | -2.14% | -$1.26M | <0.01 | |
| The Vanguard Group | $45.54M | 8.26 | 4.3M | +4.38% | +$1.91M | <0.01 | |
| State Street | $44.44M | 8.06 | 4.2M | +50.07% | +$14.83M | <0.01 | |
| Bellevue Group | $41.66M | 7.55 | 3.93M | -0.53% | -$220,123.74 | 0.64 | |
| Sumitomo Mitsui Trust Holdings | $29.1M | 5.28 | 2.75M | -4.4% | -$1.34M | 0.02 | |
| Nikko Asset Management Americas Inc | $29.08M | 5.28 | 2.75M | -4.4% | -$1.34M | 0.22 | |
| Gagnon Securities | $23.78M | 4.31 | 2.25M | +7.13% | +$1.58M | 5.92 | |
| D. E. Shaw & Co. | $21.41M | 3.88 | 2.02M | -8.14% | -$1.9M | 0.02 | |
| Dimensional Fund Advisors | $15.31M | 2.78 | 1.45M | +39.08% | +$4.3M | <0.01 | |
| Renaissance Technologies | $15.09M | 2.74 | 1.42M | +4.59% | +$661,896.32 | 0.02 | |
| Bamco | $13.02M | 2.36 | 1.23M | New | +$13.02M | 0.04 | |
| Geode Capital Management | $12.66M | 2.29 | 1.2M | +3.12% | +$382,350.80 | <0.01 | |
| Jacobs Levy Equity Management | $12.19M | 2.21 | 1.15M | +8.72% | +$978,124.13 | 0.04 | |
| First Eagle Investment Management | $10.64M | 1.93 | 1.01M | -11.15% | -$1.34M | 0.02 | |
| Morgan Stanley | $9.88M | 1.79 | 932,617 | -40.91% | -$6.84M | <0.01 | |
| Acadian Asset Management | $9.21M | 1.67 | 869,518 | +4.68% | +$411,725.72 | 0.03 | |
| Gagnon Advisors LLC | $6.46M | 1.17 | 610,336 | +10% | +$587,586.13 | 6.22 | |
| Bank of Montreal | $6.49M | 1.12 | 584,056 | -0.25% | -$16,042.84 | <0.01 | |
| Charles Schwab | $6.02M | 1.09 | 568,500 | +28.05% | +$1.32M | <0.01 | |
| ROYCE & ASSOCIATES INC | $5.7M | 1.03 | 538,298 | +56.62% | +$2.06M | 0.05 | |
| Goldman Sachs | $5.62M | 1.02 | 530,266 | +13.03% | +$647,313.76 | <0.01 | |
| AQR Capital | $4.76M | 0.86 | 449,141 | +123.87% | +$2.63M | 0.01 | |
| Northern Trust | $4.65M | 0.84 | 439,032 | -1.75% | -$82,612.59 | <0.01 | |
| Citigroup | $4.15M | 0.75 | 391,821 | +373.57% | +$3.27M | <0.01 | |
| Rafferty Asset Management Llc | $3.86M | 0.7 | 364,799 | +91.6% | +$1.85M | 0.01 | |
| Assenagon Asset Management S.A. | $3.78M | 0.69 | 356,573 | -38.13% | -$2.33M | 0.01 | |
| Cadian Capital Management LP | $3.21M | 0.58 | 303,106 | New | +$3.21M | 0.11 | |
| Cubist Systematic Strategies | $2.9M | 0.53 | 273,849 | +26.08% | +$599,881.16 | 0.03 | |
| Marshall Wace | $2.82M | 0.51 | 266,713 | +489.26% | +$2.35M | <0.01 | |
| Connor Clark & Lunn Investment Management Ltd | $2.77M | 0.5 | 261,745 | +55.51% | +$989,423.86 | 0.01 | |
| Los Angeles Capital Management LLC | $2.74M | 0.5 | 259,007 | +9.23% | +$231,836.27 | 0.01 | |
| Mirae Asset Global Investments Co Ltd | $2.03M | 0.44 | 228,198 | +87.76% | +$950,873.82 | <0.01 | |
| UBS | $2.4M | 0.43 | 226,166 | +61.12% | +$908,558.48 | <0.01 | |
| Arrowstreet Capital, Limited Partnership | $2.3M | 0.42 | 216,891 | -37.3% | -$1.37M | <0.01 | |
| Engineers Gate Manager Lp | $2.01M | 0.36 | 189,594 | +14.26% | +$250,569.93 | 0.05 | |
| Wellington Management Company | $2M | 0.36 | 188,710 | +126.98% | +$1.12M | <0.0001 | |
| Ameriprise Financial | $1.99M | 0.36 | 187,998 | -0.89% | -$17,770.02 | <0.01 | |
| Two Sigma Advisers LP | $1.99M | 0.36 | 187,700 | -18% | -$436,308.00 | <0.01 | |
| Alger | $1.97M | 0.36 | 186,048 | New | +$1.97M | 0.01 | |
| State of Wisconsin Investment Board | $1.96M | 0.36 | 185,513 | +154.08% | +$1.19M | 0.01 | |
| BNY Mellon | $1.92M | 0.35 | 181,590 | -6.62% | -$136,293.29 | <0.0001 | |
| Millennium Management LLC | $1.91M | 0.35 | 180,601 | -30.02% | -$820,312.17 | <0.01 | |
| Bullseye Asset Management LLC | $1.85M | 0.34 | 174,820 | 0% | +$0 | 0.87 | |
| Bank of America | $1.78M | 0.32 | 168,473 | -28.1% | -$697,150.26 | <0.0001 | |
| Deutsche Bank | $1.56M | 0.28 | 146,916 | +0.46% | +$7,148.25 | <0.01 | |
| Nuveen | $1.45M | 0.26 | 137,260 | 0% | +$0 | <0.0001 | |
| ARS Investment Partners, LLC | $1.42M | 0.26 | 134,110 | -11.48% | -$184,266.01 | 0.14 | |
| Prudential Financial | $1.36M | 0.25 | 128,044 | -45.08% | -$1.11M | <0.01 | |
| Russell Investments Group Ltd | $1.29M | 0.24 | 122,227 | +34.97% | +$335,353.29 | <0.01 |